# GAP Inc: financial statements, quarterly

GAP · NYSE · CIK 39911 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 1

Pages: [Overview](/companies/gap.md) · [Financials](/companies/gap/financials.md) · [Filings](/companies/gap/filings.md) · [Insiders](/companies/gap/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gap/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,767](/filings/0000039911-24-000202.md) | [4,298 d](/filings/0001628280-26-018573.md) | [3,388](/filings/0000039911-25-000079.md) | [3,720](/filings/0000039911-25-000111.md) | [3,829](/filings/0001628280-25-053934.md) | [4,149 d](/filings/0001628280-26-018573.md) | [3,463](/filings/0001628280-26-039070.md) | [3,725](/filings/0001628280-26-059345.md) | [3,942](/filings/0001628280-25-053934.md) | [4,236 d](/filings/0001628280-26-018573.md) | [3,497](/filings/0001628280-26-039070.md) | [3,651](/filings/0001628280-26-059345.md) |
| Cost of revenue | $m | [2,211](/filings/0000039911-24-000202.md) | [2,626 d](/filings/0001628280-26-018573.md) | [1,991](/filings/0000039911-25-000079.md) | [2,137](/filings/0000039911-25-000111.md) | [2,194](/filings/0001628280-25-053934.md) | [2,537 d](/filings/0001628280-26-018573.md) | [2,015](/filings/0001628280-26-039070.md) | [2,189](/filings/0001628280-26-059345.md) | [2,272](/filings/0001628280-25-053934.md) | [2,622 d](/filings/0001628280-26-018573.md) | [2,080](/filings/0001628280-26-039070.md) | [1,722](/filings/0001628280-26-059345.md) |
| Gross profit | $m | [1,556](/filings/0000039911-24-000202.md) | [1,672 d](/filings/0001628280-26-018573.md) | [1,397](/filings/0000039911-25-000079.md) | [1,583](/filings/0000039911-25-000111.md) | [1,635](/filings/0001628280-25-053934.md) | [1,612 d](/filings/0001628280-26-018573.md) | [1,448](/filings/0001628280-26-039070.md) | [1,536](/filings/0001628280-26-059345.md) | [1,670](/filings/0001628280-25-053934.md) | [1,614 d](/filings/0001628280-26-018573.md) | [1,417](/filings/0001628280-26-039070.md) | [1,929](/filings/0001628280-26-059345.md) |
| Operating income | $m | [250](/filings/0000039911-24-000202.md) | [214 d](/filings/0001628280-26-018573.md) | [205](/filings/0000039911-25-000079.md) | [293](/filings/0000039911-25-000111.md) | [355](/filings/0001628280-25-053934.md) | [259 d](/filings/0001628280-26-018573.md) | [260](/filings/0001628280-26-039070.md) | [292](/filings/0001628280-26-059345.md) | [334](/filings/0001628280-25-053934.md) | [229 d](/filings/0001628280-26-018573.md) | [445](/filings/0001628280-26-039070.md) | [676](/filings/0001628280-26-059345.md) |
| Interest expense | $m | [28.0](/filings/0000039911-24-000202.md) | [24.0 d](/filings/0001628280-26-018573.md) | [21.0](/filings/0000039911-25-000079.md) | [24.0](/filings/0000039911-25-000111.md) | [23.0](/filings/0001628280-25-053934.md) | [19.0 d](/filings/0001628280-26-018573.md) | [23.0](/filings/0001628280-26-039070.md) | [23.0](/filings/0001628280-26-059345.md) | [23.0](/filings/0001628280-25-053934.md) | [24.0 d](/filings/0001628280-26-018573.md) | [22.0](/filings/0001628280-26-039070.md) | [24.0](/filings/0001628280-26-059345.md) |
| Income tax | $m | [32.0](/filings/0000039911-24-000202.md) | [33.0 d](/filings/0001628280-26-018573.md) | [50.0](/filings/0000039911-25-000079.md) | [90.0](/filings/0000039911-25-000111.md) | [87.0](/filings/0001628280-25-053934.md) | [66.0 d](/filings/0001628280-26-018573.md) | [70.0](/filings/0001628280-26-039070.md) | [80.0](/filings/0001628280-26-059345.md) | [101](/filings/0001628280-25-053934.md) | [65.0 d](/filings/0001628280-26-018573.md) | [111](/filings/0001628280-26-039070.md) | [179](/filings/0001628280-26-059345.md) |
| Net income | $m | [218](/filings/0000039911-24-000202.md) | [185 d](/filings/0001628280-26-018573.md) | [158](/filings/0000039911-25-000079.md) | [206](/filings/0000039911-25-000111.md) | [274](/filings/0001628280-25-053934.md) | [206 d](/filings/0001628280-26-018573.md) | [193](/filings/0001628280-26-039070.md) | [216](/filings/0001628280-26-059345.md) | [236](/filings/0001628280-25-053934.md) | [171 d](/filings/0001628280-26-018573.md) | [339](/filings/0001628280-26-039070.md) | [501](/filings/0001628280-26-059345.md) |
| Diluted EPS | $ per share | [0.58](/filings/0000039911-24-000202.md) | not reported | [0.41](/filings/0000039911-25-000079.md) | [0.54](/filings/0000039911-25-000111.md) | [0.72](/filings/0001628280-25-053934.md) | not reported | [0.51](/filings/0001628280-26-039070.md) | [0.57](/filings/0001628280-26-059345.md) | [0.62](/filings/0001628280-25-053934.md) | not reported | [0.90](/filings/0001628280-26-039070.md) | [1.38](/filings/0001628280-26-059345.md) |
| Basic EPS | $ per share | [0.59](/filings/0000039911-24-000202.md) | not reported | [0.42](/filings/0000039911-25-000079.md) | [0.55](/filings/0000039911-25-000111.md) | [0.73](/filings/0001628280-25-053934.md) | not reported | [0.51](/filings/0001628280-26-039070.md) | [0.58](/filings/0001628280-26-059345.md) | [0.63](/filings/0001628280-25-053934.md) | not reported | [0.92](/filings/0001628280-26-039070.md) | [1.41](/filings/0001628280-26-059345.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0000039911-24-000202.md) | [1.9](/filings/0001628280-26-018573.md) | [1.5](/filings/0000039911-25-000079.md) | [1.9](/filings/0000039911-25-000111.md) | [2.0](/filings/0001628280-25-053934.md) | [2.3](/filings/0001628280-26-018573.md) | [2.0](/filings/0001628280-26-039070.md) | [2.2](/filings/0001628280-26-059345.md) | [2.3](/filings/0001628280-25-053934.md) | [2.6](/filings/0001628280-26-059345.md) | [2.2](/filings/0001628280-26-039070.md) | [2.1](/filings/0001628280-26-059345.md) |
| Current assets | $bn | [4.4](/filings/0000039911-24-000202.md) | [4.4](/filings/0000039911-25-000029.md) | [4.2](/filings/0000039911-25-000079.md) | [4.8](/filings/0000039911-25-000111.md) | [5.1](/filings/0001628280-25-053934.md) | [5.2](/filings/0001628280-26-018573.md) | [4.9](/filings/0001628280-26-039070.md) | [5.4](/filings/0001628280-26-059345.md) | [5.6](/filings/0001628280-25-053934.md) | [5.8](/filings/0001628280-26-059345.md) | [5.2](/filings/0001628280-26-039070.md) | [5.9](/filings/0001628280-26-059345.md) |
| Total assets | $bn | [11.1](/filings/0000039911-24-000202.md) | [11.0](/filings/0000039911-25-000029.md) | [10.9](/filings/0000039911-25-000079.md) | [11.5](/filings/0000039911-25-000111.md) | [11.9](/filings/0001628280-25-053934.md) | [11.9](/filings/0001628280-26-018573.md) | [11.6](/filings/0001628280-26-039070.md) | [12.1](/filings/0001628280-26-059345.md) | [12.4](/filings/0001628280-25-053934.md) | [12.6](/filings/0001628280-26-059345.md) | [12.1](/filings/0001628280-26-039070.md) | [12.9](/filings/0001628280-26-059345.md) |
| Current liabilities | $bn | [3.1](/filings/0000039911-24-000202.md) | [3.1](/filings/0000039911-25-000029.md) | [2.8](/filings/0000039911-25-000079.md) | [3.2](/filings/0000039911-25-000111.md) | [3.3](/filings/0001628280-25-053934.md) | [3.3](/filings/0001628280-26-018573.md) | [2.9](/filings/0001628280-26-039070.md) | [3.2](/filings/0001628280-26-059345.md) | [3.3](/filings/0001628280-25-053934.md) | [3.3](/filings/0001628280-26-059345.md) | [2.9](/filings/0001628280-26-039070.md) | [3.2](/filings/0001628280-26-059345.md) |
| Long-term debt | $bn | [1.5](/filings/0000039911-24-000202.md) | [1.5](/filings/0000039911-25-000029.md) | [1.5](/filings/0000039911-25-000079.md) | [1.5](/filings/0000039911-25-000111.md) | [1.5](/filings/0001628280-25-053934.md) | [1.5](/filings/0001628280-26-018573.md) | [1.5](/filings/0001628280-26-039070.md) | [1.5](/filings/0001628280-26-059345.md) | [1.5](/filings/0001628280-25-053934.md) | [1.5](/filings/0001628280-26-059345.md) | [1.5](/filings/0001628280-26-039070.md) | [1.5](/filings/0001628280-26-059345.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.5](/filings/0000039911-24-000202.md) | [2.6](/filings/0001628280-26-018573.md) | [2.7](/filings/0000039911-25-000111.md) | [2.9](/filings/0001628280-25-053934.md) | [3.1](/filings/0001628280-25-053934.md) | [3.3](/filings/0001628280-26-059345.md) | [3.3](/filings/0001628280-26-059345.md) | [3.4](/filings/0001628280-26-059345.md) | [3.6](/filings/0001628280-25-053934.md) | [3.8](/filings/0001628280-26-059345.md) | [3.7](/filings/0001628280-26-059345.md) | [4.0](/filings/0001628280-26-059345.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [304 d](/filings/0000039911-24-000202.md) | [700 d](/filings/0001628280-26-018573.md) | [30.0](/filings/0000039911-25-000079.md) | [549 d](/filings/0000039911-25-000111.md) | [291 d](/filings/0001628280-25-053934.md) | [616 d](/filings/0001628280-26-018573.md) | [(140)](/filings/0001628280-26-039070.md) | [448 d](/filings/0001628280-26-059345.md) | [299 d](/filings/0001628280-25-053934.md) | [686 d](/filings/0001628280-26-018573.md) | [213](/filings/0001628280-26-039070.md) | [337 d](/filings/0001628280-26-059345.md) |
| Capital expenditure | $m | [89.0 d](/filings/0000039911-24-000202.md) | [132 d](/filings/0001628280-26-018573.md) | [93.0](/filings/0000039911-25-000079.md) | [89.0 d](/filings/0000039911-25-000111.md) | [148 d](/filings/0001628280-25-053934.md) | [117 d](/filings/0001628280-26-018573.md) | [83.0](/filings/0001628280-26-039070.md) | [98.0 d](/filings/0001628280-26-059345.md) | [146 d](/filings/0001628280-25-053934.md) | [143 d](/filings/0001628280-26-018573.md) | [135](/filings/0001628280-26-039070.md) | [154 d](/filings/0001628280-26-059345.md) |
| Dividends paid | $m | [55.0 d](/filings/0000039911-24-000202.md) | [56.0 d](/filings/0001628280-26-018573.md) | [56.0](/filings/0000039911-25-000079.md) | [56.0 d](/filings/0000039911-25-000111.md) | [57.0 d](/filings/0001628280-25-053934.md) | [56.0 d](/filings/0001628280-26-018573.md) | [61.0](/filings/0001628280-26-039070.md) | [62.0 d](/filings/0001628280-26-059345.md) | [62.0 d](/filings/0001628280-25-053934.md) | [62.0 d](/filings/0001628280-26-018573.md) | [63.0](/filings/0001628280-26-039070.md) | [62.0 d](/filings/0001628280-26-059345.md) |
| Share repurchases | $m | [0.0 d](/filings/0000039911-23-000132.md) | [0.0 d](/filings/0001628280-26-018573.md) | [0.0](/filings/0000039911-25-000079.md) | [0.0 d](/filings/0000039911-25-000111.md) | [0.0 d](/filings/0001628280-25-053934.md) | [75.0 d](/filings/0001628280-26-018573.md) | [70.0](/filings/0001628280-26-039070.md) | [82.0 d](/filings/0001628280-26-059345.md) | [0.0 d](/filings/0001628280-25-053934.md) | [3.0 d](/filings/0001628280-26-018573.md) | [401](/filings/0001628280-26-039070.md) | [200 d](/filings/0001628280-26-059345.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [366](/filings/0000039911-23-000132.md) | [367](/filings/0000039911-24-000128.md) | [371](/filings/0000039911-24-000179.md) | [375](/filings/0000039911-24-000202.md) | [383](/filings/0000039911-25-000079.md) | [383](/filings/0000039911-25-000111.md) | [383](/filings/0001628280-25-053934.md) | [382](/filings/0001628280-26-039070.md) | [379](/filings/0001628280-26-059345.md) | [380](/filings/0001628280-25-053934.md) | [378](/filings/0001628280-26-039070.md) | [362](/filings/0001628280-26-059345.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 351,270,137 at 2026-08-21, from the cover of the [10-Q filed 2026-08-28](/filings/0001628280-26-059345.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.